Home / Recalls / Orexigen Therapeutics, Inc. / D-1099-2018

D-1099-2018 Class III Terminated

Recalled by Orexigen Therapeutics, Inc. — La Jolla, CA

Recall Details

Product Type: Drugs
Report Date: August 22, 2018
Initiation Date: August 9, 2018
Termination Date: November 15, 2019
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 95,296 bottles

Product Description

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Reason for Recall

Defective Container: Customer complaints of punctures in the bottle.

Distribution Pattern

Nationwide in the USA

Code Information

Lot #: ZCXM, Exp 01NOV2020; ZCXN, Exp 02NOV2020; ZCXP, Exp 09NOV2020; ZCXS, 10NOV2020; ZCXT, Exp 13NOV2020; and ZCXV, Exp 17NOV2020